University of Colorado Details Findings in COVID-19 (The Risk of Allergic Reaction To Sars-cov-2 Vaccines and Recommended Evaluation and Management: a Systematic Review, Meta-analysis, Grade Assessment, and International Consensus Approach)

MLA

“University of Colorado Details Findings in COVID-19 (The Risk of Allergic Reaction To Sars-Cov-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, Grade Assessment, and International Consensus Approach).” Vaccine Weekly, 19 Jan. 2022, p. 762. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.689648842&authtype=sso&custid=ns315887.

APA

University of Colorado Details Findings in COVID-19 (The Risk of Allergic Reaction To Sars-cov-2 Vaccines and Recommended Evaluation and Management: a Systematic Review, Meta-analysis, Grade Assessment, and International Consensus Approach). (2022, January 19). Vaccine Weekly, 762.

Chicago

Vaccine Weekly. 2022. “University of Colorado Details Findings in COVID-19 (The Risk of Allergic Reaction To Sars-Cov-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, Grade Assessment, and International Consensus Approach),” January 19. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.689648842&authtype=sso&custid=ns315887.